Newsfeed : Pittsburgh Researcher Granted $17.5 Million to Develop Rectal Microbicide Gel

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Newsfeed » January 2010

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


January 14, 2010

Pittsburgh Researcher Granted $17.5 Million to Develop Rectal Microbicide Gel

University of Pittsburgh researcher Ian McGowan, MD, has received two grants from the National Institutes of Health (NIH) totaling $17.5 million to research and develop a rectal microbicide gel to prevent HIV transmission through anal sex, the Pittsburgh Post-Gazette reports. Topical microbicides are typically developed for vaginal application to prevent male-to-female HIV transmission.

McGowan’s five-year Combination HIV Antiretroviral Rectal Microbicide program will use existing, yet-to-be-licensed HIV microbicides to develop a topical rectal gel, while a separate, four-year Microbicide Safety and Acceptability in Young Men project will measure young men’s willingness to use the gel.

McGowan applauded President Obama’s commitment to funding HIV research and his support of prevention programs that include men who have sex with men (MSM).

“The Bush administration had a very high level of discomfort embracing HIV prevention research in men,” he said. “But I think in the Obama administration that’s a nonissue. They regard domestic HIV prevention in men who have sex with men as an important research priority.”

McGowan added that heterosexual couples also engage in anal sex, further validating the need for rectal microbicides.

“There’s increasing evidence that men and women have anal sex too,” McGowan said. “If we are interested in HIV prevention, we have to look at options for both men and women.”

Search: rectal microbicide, microbicide, anal sex, MSM, University of Pittsburgh, National Institutes of Health, NIH

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.